110
Views
44
CrossRef citations to date
0
Altmetric
Original Research

Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer

, , , , , , , , & show all
Pages 7433-7451 | Published online: 11 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Mingliang Fan, Yue Huang, Xinlin Zhu, Jiayu Zheng & Mingwei Du. (2023) Octreotide and Octreotide-derived delivery systems. Journal of Drug Targeting 31:6, pages 569-584.
Read now
Deepika Radhakrishnan, Shan Mohanan, Goeun Choi, Jin-Ho Choy, Steffi Tiburcius, Hoang Trung Trinh, Shankar Bolan, Nikki Verrills, Pradeep Tanwar, Ajay Karakoti & Ajayan Vinu. (2022) The emergence of nanoporous materials in lung cancer therapy. Science and Technology of Advanced Materials 23:1, pages 225-274.
Read now
Xue-Tao Li, Ming Jing, Fu-Yi Cai, Xue-Min Yao, Liang Kong & Xiao-Bo Wang. (2021) Enhanced antitumour efficiency of R8GD-modified epirubicin plus tetrandrine liposomes in treatment of gastric cancer via inhibiting tumour metastasis. Journal of Liposome Research 31:2, pages 145-157.
Read now
Ming Jing, Xiao-Jie Bi, Xue-Min Yao, Fuyi Cai, Jing-Jing Liu, Min Fu, Liang Kong, Xin-Ze Liu, Lu Zhang, Si-Yu He, Lian-Qun Jia & Xue-Tao Li. (2020) Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis. Drug Development and Industrial Pharmacy 46:4, pages 621-634.
Read now
Min Fu, Wei Tang, Jing-Jing Liu, Xiao-Qing Gong, Liang Kong, Xue-Min Yao, Ming Jing, Fu-Yi Cai, Xue-Tao Li & Rui-Jun Ju. (2020) Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer. Journal of Drug Targeting 28:3, pages 245-258.
Read now
Henry Lujan, Wezley C Griffin, Joseph H Taube & Christie M Sayes. (2019) Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells. International Journal of Nanomedicine 14, pages 5159-5173.
Read now
Yuanyuan Wang, Min Fu, Jingjing Liu, Yining Yang, Yibin Yu, Jinyu Li, Weisan Pan, Lei Fan, Guiru Li, Xuetao Li & Xiaobo Wang. (2019) Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer. International Journal of Nanomedicine 14, pages 4071-4090.
Read now
Jing-Jing Liu, Wei Tang, Min Fu, Xiao-Qing Gong, Liang Kong, Xue-Min Yao, Ming Jing, Fu-Yi Cai, Xue-Tao Li & Rui-Jun Ju. (2019) Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1947-1960.
Read now
Quan An, Chen-Xiao Shi, Hao Guo, Shi-Min Xie, Ying-Ying Yang, Ying-Nan Liu, Zi-Hao Liu, Chang-Zheng Zhou & Feng-Ju Niu. (2019) Development and characterization of octreotide-modified curcumin plus docetaxel micelles for potential treatment of non-small-cell lung cancer. Pharmaceutical Development and Technology 24:9, pages 1164-1174.
Read now
Yao Xiao, Lan Cheng, Hong-jun Xie, Rui-jun Ju, Xin Wang, Min Fu, Jing-jing Liu & Xue-tao Li. (2018) Vinorelbine cationic liposomes modified with wheat germ agglutinin for inhibiting tumor metastasis in treatment of brain glioma. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 524-537.
Read now

Articles from other publishers (33)

Xiaohui Zhang, Haofei Huang, Xin Lang, Ziyan Chen, Huajing Zeng, Yaowen Chang & Yingying Nie. (2023) A 3D-printed PCL/PEI/DNA bioactive scaffold for chemotherapy drug capture in vivo. International Journal of Biological Macromolecules 236, pages 123942.
Crossref
Sevde Altuntas. (2023) The effects of epirubicin-loaded Boc-L-Diphenylalanine peptide nanoparticles on cytotoxicity, genotoxicity, oxidative stress, and apoptosis in non-small cell lung cancer cells. Food and Chemical Toxicology 175, pages 113690.
Crossref
Chanhee Oh, Ok Hwa Jeon, Junhee Han, Kyungsu Kim, Hyun Koo Kim & Ji-Ho Park. (2023) Pulmonary Surfactant-Based Paclitaxel-Loaded Nanovesicles for Inhalation Therapy of Lung Adenocarcinoma. ACS Applied Nano Materials 6:5, pages 3693-3703.
Crossref
Akshansh Sharma, Devanshi Shambhwani, Sadanand Pandey, Jay Singh, Hauzel Lalhlenmawia, Murali Kumarasamy, Sachin Kumar Singh, Dinesh Kumar Chellappan, Gaurav Gupta, Parteek Prasher, Kamal Dua & Deepak Kumar. (2022) Advances in Lung Cancer Treatment Using Nanomedicines. ACS Omega 8:1, pages 10-41.
Crossref
Leila Gholami, Jalil Rouhani Ivari, Niloofar Khandan Nasab, Reza Kazemi Oskuee, Thozhukat Sathyapalan & Amirhossein Sahebkar. (2023) Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review. Current Medicinal Chemistry 30:3, pages 335-355.
Crossref
Harikrishnareddy Rachamalla, Anubhab Mukherjee & Manash K. Paul. 2022. Cell Culture - Advanced Technology and Applications in Medical and Life Sciences. Cell Culture - Advanced Technology and Applications in Medical and Life Sciences.
Onur Aydin, Austin P. Passaro, Ritu Raman, Samantha E. Spellicy, Robert P. Weinberg, Roger D. Kamm, Matthew Sample, George A. Truskey, Jeremiah Zartman, Roy D. Dar, Sebastian Palacios, Jason Wang, Jesse Tordoff, Nuria Montserrat, Rashid Bashir, M. Taher A. Saif & Ron Weiss. (2022) Principles for the design of multicellular engineered living systems. APL Bioengineering 6:1.
Crossref
Dinesh Kumar Chellappan, Parteek Prasher, Vilashini Saravanan, Vanessa See Vern Yee, Wendy Chai Wen Chi, Jia Wei Wong, Joon Kang Wong, Jing Tong Wong, Wai Wan, Jestin Chellian, Nagashekhara Molugulu, Sakthivel Lakshmana Prabu, Rania Ibrahim, Thiviya Darmarajan, Mayuren Candasamy, Pankaj Kumar Singh, Vijay Mishra, Madhur D. Shastri, Flavia C. Zacconi, Amlan Chakraborty, Meenu Mehta, Piyush Kumar Gupta, Harish Dureja, Monica Gulati, Sachin Kumar Singh, Gaurav Gupta, Niraj Kumar Jha, Brian Gregory George Oliver & Kamal Dua. (2022) Protein and peptide delivery to lungs by using advanced targeted drug delivery. Chemico-Biological Interactions 351, pages 109706.
Crossref
Monika Yadav & Anita Kamra Verma. 2022. Microbiome in Inflammatory Lung Diseases. Microbiome in Inflammatory Lung Diseases 359 377 .
Shruti Rawal & Mayur Patel. (2021) Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers. Nano-Micro Letters 13:1.
Crossref
Krishan Kumar & Ruchi Chawla. (2021) Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer. Journal of Drug Delivery Science and Technology 65, pages 102677.
Crossref
Chen Jing, Li Yan, Zhang Wei, Zhang Shoumin, Yin Guangwen, Zhang Jiangan, Jia Xuesong, Chen Hongxiang, Duan Ziyu & Li Jianguo. (2020) Exogenous delivery of microRNA-134 (miR-134) using α-tocopherol-based PEGylated liposome for effective treatment in skin squamous cell carcinoma. Drug Delivery and Translational Research 11:3, pages 1000-1008.
Crossref
Ejaj Ahmad, Asgar Ali, Munazza Tamkeen Fatima, Nimisha, Apurva, Arun Kumar, Mamta P. Sumi, Real Sumayya Abdul Sattar, Bhawna Mahajan & Sundeep Singh Saluja. (2021) Ligand decorated biodegradable nanomedicine in the treatment of cancer. Pharmacological Research 167, pages 105544.
Crossref
Irisvan S. Ribeiro, Francisco J.G. Pontes, Maria J.M. Carneiro, Nayara A. Sousa, Vicente P.T. Pinto, Fábio O.S. Ribeiro, Durcilene A. Silva, Gisele S. Araújo, José D.B. Marinho Filho, Ana J. Araújo, Haroldo C.B. Paula, Judith P.A. Feitosa & Regina C.M. de Paula. (2021) Poly(ε-caprolactone) grafted cashew gum nanoparticles as an epirubicin delivery system. International Journal of Biological Macromolecules 179, pages 314-323.
Crossref
Ariana Abawi, Xiaoyi Wang, Julien Bompard, Anna Bérot, Valentina Andretto, Leslie Gudimard, Chloé Devillard, Emma Petiot, Benoit Joseph, Giovanna Lollo, Thierry Granjon, Agnès Girard-Egrot & Ofelia Maniti. (2021) Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines. International Journal of Molecular Sciences 22:8, pages 4103.
Crossref
Fakhara Sabir, Maimoona Qindeel, Mahira Zeeshan, Qurrat Ul Ain, Abbas Rahdar, Mahmood Barani, Edurne González & M. Ali Aboudzadeh. (2021) Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review. Processes 9:4, pages 621.
Crossref
Geanina Ștefan, Oana Hosu, Karolien De Wael, María Jesús Lobo-Castañón & Cecilia Cristea. (2021) Aptamers in biomedicine: Selection strategies and recent advances. Electrochimica Acta 376, pages 137994.
Crossref
Christopher Woodman, Gugulethu Vundu, Alex George & Cornelia M. Wilson. (2021) Applications and strategies in nanodiagnosis and nanotherapy in lung cancer. Seminars in Cancer Biology 69, pages 349-364.
Crossref
Joydeb Majumder & Tamara Minko. (2020) Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus. Advanced Therapeutics 4:2, pages 2000203.
Crossref
Xiaoxu Wei, Yunhua Chen, Xianjie Jiang, Miao Peng, Yiduo Liu, Yongzhen Mo, Daixi Ren, Yuze Hua, Boyao Yu, Yujuan Zhou, Qianjin Liao, Hui Wang, Bo Xiang, Ming Zhou, Xiaoling Li, Guiyuan Li, Yong Li, Wei Xiong & Zhaoyang Zeng. (2021) Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Molecular Cancer 20:1.
Crossref
Wei Wang, Yuhao Hao, Yusheng Liu, Rui Li, Da‐Bing Huang & Yue‐Yin Pan. (2020) Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 13:1.
Crossref
Jigar D. Vanza, Rashmin B. Patel & Mrunali R. Patel. (2020) Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer. Journal of Drug Delivery Science and Technology 60, pages 102070.
Crossref
Arpit Bhargava, Dinesh Kumar Mishra, Rajnarayan Tiwari, Nirmal Kumar Lohiya, Irina Yu Goryacheva & Pradyumna Kumar Mishra. (2020) Immune cell engineering: opportunities in lung cancer therapeutics. Drug Delivery and Translational Research 10:5, pages 1203-1227.
Crossref
Nikita Sharma, R. Mankamna Kumari, Nidhi Gupta, Asad Syed, Ali H. Bahkali & Surendra Nimesh. (2020) Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells. Molecules 25:18, pages 4243.
Crossref
Julien Bompard, Annalisa Rosso, Leyre Brizuela, Saïda Mebarek, Loïc J. Blum, Ana-Maria Trunfio-Sfarghiu, Giovanna Lollo, Thierry Granjon, Agnès Girard-Egrot & Ofelia Maniti. (2020) Membrane Fluidity as a New Means to Selectively Target Cancer Cells with Fusogenic Lipid Carriers. Langmuir 36:19, pages 5134-5144.
Crossref
Vineela Parvathaneni, Nishant S. Kulkarni, Snehal K. Shukla, Pamela T. Farrales, Nitesh K. Kunda, Aaron Muth & Vivek Gupta. (2020) Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment. Pharmaceutics 12:3, pages 206.
Crossref
Liang Kong, Fu‐yi Cai, Xue‐min Yao, Ming Jing, Min Fu, Jing‐jing Liu, Si‐yu He, Lu Zhang, Xin‐ze Liu, Rui‐jun Ju & Xue‐tao Li. (2020) RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply. Cancer Science 111:2, pages 621-636.
Crossref
Hae Hyun Hwang & Dong Yun Lee. 2020. Bioinspired Biomaterials. Bioinspired Biomaterials 203 221 .
Jing Qu, Si Peng, Rui Wang, Sheng-tao Yang, Qing-han Zhou & Juan Lin. (2019) Stepwise pH-sensitive and biodegradable polypeptide hybrid micelles for enhanced cellular internalization and efficient nuclear drug delivery. Colloids and Surfaces B: Biointerfaces 181, pages 315-324.
Crossref
Anubhab Mukherjee, Manash Paul & Sudip Mukherjee. (2019) Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer. Cancers 11:5, pages 597.
Crossref
Amirhossein Bahreyni, Mona Alibolandi, Mohammad Ramezani, Atefeh Sarafan Sadeghi, Khalil Abnous & Seyed Mohammad Taghdisi. (2019) A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo. Colloids and Surfaces B: Biointerfaces 175, pages 231-238.
Crossref
. (2019) Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer. Pharmaceutical Frontiers.
Crossref
Paulina Skupin-Mrugalska. 2019. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer 123 160 .